Sinocare
Changsha, Jiangsu, China · Founded 2002
About Sinocare
Sinocare Inc. has been dedicating itself to bio-sensor technology research & development, manufacturing and marketing of POCT products since its establishment in Aug,2002. Sinocare focuses intensively and extensively on the R&D of products and innovation of technology, casting our look into the future, to deliver significant benefits for people pursuing healthy living. Sinocare Blood Glucose Monitoring System(BGMS) wins the recognition of various consumers attributing to its accuracy, simplicity and affordability. The product is not only popular in China, but also exported to many countries in large scale. By adhering to the values of “equality, honesty, innovation and excellence", Sinocare has been working on innovation to be the "portable laboratory" based on POCT products. We aim at providing quality products and services for patients with diabetes or other chronic disease in China, to improve their living quality and relieve the burden of our social healthcare system.
Company Facts
- Founded: 2002
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $500K – $1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jan 2016)
- Ticker: szse:300298
- Website: en.sinocare.com
- Phone: +08689935581
Industries & Categories
Biotechnology, Manufacturing, Sensor
Social Profiles
Canonical: https://fsome.com/organization/sinocare-2491414 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.